» Articles » PMID: 38166872

Dyslipidemia and Hyperuricemia: a Cross-sectional Study of Residents in Wuhu, China

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2024 Jan 3
PMID 38166872
Authors
Affiliations
Soon will be listed here.
Abstract

Background: While dyslipidemia has been recognized as a potential risk factor for hyperuricemia, there is currently a dearth of large-scale data specifically focused on studying the relationship between these two conditions. To address this gap, the present study analyzed a dataset of 298,891 physical examination records to investigate in greater detail the clinical classification and compositional relationship between hyperuricemia and dyslipidemia.

Methods: For this investigation, a cross-sectional research design was utilized to analyze physical examination data that was gathered from Yijishan Hospital in Wuhu, China between 2011 and 2016. Logistic regression was employed to examine the association between hyperuricemia and dyslipidemia. Furthermore, the association between hyperuricemia and dyslipidemia was evaluated based on the clinical classifications of dyslipidemia and its components.

Results: A total of 298,891 participants from China (124,886 [41.8%] females) were included in the study, with an age range of 18 to 90 years (mean [SD]: 47.76 [13.54] years). In multivariate analysis, the odds of hyperuricemia was 1.878 times higher in patients with dyslipidemia compared to those without dyslipidemia (95% confidence interval [CI]: 1.835-1.922). In the clinical classification of dyslipidemia, individuals with hypertriglyceridemia and mixed hyperlipidemia had 1.753 times (95% CI: 1.706-1.802) and 1.925 times (95% CI: 1.870-1.982) higher odds of hyperuricemia, respectively, compared to those without dyslipidemia. Among the components of dyslipidemia, the odds ratios for hyperuricemia in individuals in the fourth quartile compared to those in the first quartile were 3.744 (95% CI: 3.636-3.918) for triglycerides, 1.518 (95% CI: 1.471-1.565) for total cholesterol, and 1.775 (95% CI: 1.718 - 1.833) for non-high-density lipoprotein cholesterol.

Conclusions: Dyslipidemia has been independently linked with hyperuricemia. Moreover, the elevation of triglycerides or total cholesterol levels, including conditions such as hypertriglyceridemia and mixed hyperlipidemia, have been observed to have a positive association with the development of hyperuricemia.

Citing Articles

259 alleviates hyperuricemia in rats by decreasing uric acid and modulating the gut microbiota.

Bi C, Zhang L, Liu J, Chen L Front Nutr. 2024; 11:1450284.

PMID: 39600720 PMC: 11588492. DOI: 10.3389/fnut.2024.1450284.


Association between life's essential 8 and hyperuricemia among adults in the United States: insights from NHANES 2005-2018.

Wang X, Fan J Front Med (Lausanne). 2024; 11:1455164.

PMID: 39568733 PMC: 11576210. DOI: 10.3389/fmed.2024.1455164.


Serum Uric Acid and Iron Status: Exploring a Complex Interaction in Metabolic Syndrome Patients of Eastern India.

Maiti S, Pal S, Chatterjee D, Dasgupta A, Podder A Cureus. 2024; 16(10):e70803.

PMID: 39493039 PMC: 11531647. DOI: 10.7759/cureus.70803.


A study on the correlation between hyperuricemia and TG/HDL-c ratio in the Naxi ethnic group at high-altitude regions of Yunnan.

Han D, Yao Y, Wang F, He W, Sun T, Li H Front Med (Lausanne). 2024; 11:1416021.

PMID: 39188875 PMC: 11345255. DOI: 10.3389/fmed.2024.1416021.


Nonlinear association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and hyperuricemia in cancer patients: evidence from NHANES 2007-2018.

He R, Zhu Q, Ye Y, Chen S, Xie C Lipids Health Dis. 2024; 23(1):269.

PMID: 39187886 PMC: 11346297. DOI: 10.1186/s12944-024-02261-3.


References
1.
Huang X, Zhang W, Tang W, Liu Y, Ning Y, Huang C . Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study. Sci Rep. 2020; 10(1):15683. PMC: 7515884. DOI: 10.1038/s41598-020-72780-3. View

2.
Zhang Y, Yu H, Chai S, Chai X, Wang L, Geng W . Noninvasive and Individual-Centered Monitoring of Uric Acid for Precaution of Hyperuricemia via Optical Supramolecular Sensing. Adv Sci (Weinh). 2022; 9(18):e2104463. PMC: 9218761. DOI: 10.1002/advs.202104463. View

3.
Yu Y, Huang X, Li M, Ding C, Hu L, Zhong X . Is There a Nonlinear Relationship between Serum Uric Acid and Lipids in a Hypertensive Population with eGFR ≥30 ml/min/1.73 m? Findings from the China Hypertension Registry Study. Int J Endocrinol. 2020; 2020:9725979. PMC: 7519986. DOI: 10.1155/2020/9725979. View

4.
Vekic J, Zeljkovic A, Stefanovic A, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V . Obesity and dyslipidemia. Metabolism. 2018; 92:71-81. DOI: 10.1016/j.metabol.2018.11.005. View

5.
Zhang Y, Wei F, Chen C, Cai C, Zhang K, Sun N . Higher triglyceride level predicts hyperuricemia: A prospective study of 6-year follow-up. J Clin Lipidol. 2017; 12(1):185-192. DOI: 10.1016/j.jacl.2017.10.009. View